Kairos Pharma, Ltd. (KAPA)
NYSEAMERICAN: KAPA · Real-Time Price · USD
1.316
-0.034 (-2.50%)
Nov 5, 2024, 1:03 PM EST - Market open

Kairos Pharma Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
0.020.090.440.07
Cash & Short-Term Investments
0.020.090.440.07
Cash Growth
-90.95%-78.72%498.63%-
Prepaid Expenses
0.020.01--
Total Current Assets
0.040.10.440.07
Other Intangible Assets
0.30.380.540.7
Long-Term Deferred Charges
0.690.480.06-
Total Assets
1.030.971.040.78
Accounts Payable
2.92.41.631.55
Short-Term Debt
0.11000.39
Total Current Liabilities
3.012.411.631.94
Long-Term Debt
0.680.640.58-
Total Liabilities
3.683.042.221.94
Common Stock
0.010.010.010.1
Additional Paid-In Capital
4.124.123.212.08
Retained Earnings
-6.79-6.21-4.4-3.35
Shareholders' Equity
-2.65-2.08-1.18-1.17
Total Liabilities & Equity
1.030.971.040.78
Total Debt
0.780.640.590.39
Net Cash (Debt)
-0.76-0.55-0.15-0.32
Net Cash Per Share
-0.07-0.05-0.01-0.04
Filing Date Shares Outstanding
10.5610.5610.339.15
Total Common Shares Outstanding
10.5610.5610.339.15
Working Capital
-2.97-2.3-1.2-1.87
Book Value Per Share
-0.25-0.20-0.11-0.13
Tangible Book Value
-2.96-2.46-1.72-1.87
Tangible Book Value Per Share
-0.28-0.23-0.17-0.20
Source: S&P Capital IQ. Standard template. Financial Sources.